Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15815 articles
Inhaled corticosteroids in COPD and the risk of lung cancer.
ICS, particularly at high cumulative dose, might be associated with decreased risk of lung cancer.
»
10/01/17
Endoglin expression on cancer-associated fibroblasts regulates invasion and stimulates colorectal cancer metastasis.
CAF-specific endoglin targeting with TRC105 decreased metastatic spread of murine CRC cells.
»
06/18/18
Effect of statin use on oncologic outcomes in head and neck squamous cell carcinoma.
Patients with statin exposure demonstrated improved OS.
»
07/25/17
JAK2 and PD-L1 Amplification Enhance the Dynamic Expression of PD-L1 in Triple-negative Breast Cancer.
PD-L1 expression rapidly and strikingly increased 5- to 38-fold with interferon-γ.
»
11/29/17
Co-targeting ephrin receptor tyrosine kinases A2 and A3 in cancer stem cells reduces growth of recurrent glioblastoma.
EphA2 and EphA3 together mark a GSC population in rGBM.
»
06/22/18
Cyclooxygenase inhibitors potentiate receptor tyrosine kinase therapies in bladder cancer cells in vitro.
Co-treatment of RTKIs with indomethacin inhibited cell viability.
»
06/27/18
Ineffective anti PD-1 therapy after BRAF inhibitor failure in advanced melanoma
Rapid death (≤3 months)significantly higher in BRAF-mutated patients.
»
07/03/18
Long-term outcomes of partial prostate treatment with magnetic resonance imaging-guided brachytherapy for patients with favorable-risk prostate cancer.
Partial prostate treatment with brachytherapy may be associated with higher rates of distant metastasis.
»
12/21/17
FOXA1 and AR in invasive breast cancer: new findings on their co-expression and impact on prognosis in ER-positive patients
FOXA1 may provide more information than AR in Disease-Free Interval of ER+ BC patients.
»
07/03/18
Mutant p53 gain of function induces HER2 over-expression in cancer cells
Silencing of p53 mutants decreases HER2 expression.
»
07/03/18
< Prev
Next >